DUBLIN--(BUSINESS WIRE)--Research and Markets http://www.researchandmarkets.com/research/bda0ec/vitiligo_therapeut) has announced the addition of GlobalData 's new report "Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019" to their offering.
The Vitiligo Therapeutics Market is Expected to Show Moderate Growth up to 2019
GlobalData estimated the global vitiligo therapeutics market to be worth $1.4 billion in 2011. It is expected to grow to $2.7 billion by 2019 at a Compound Annual Growth Rate (CAGR) of 8.8%. This growth can be primarily attributed to the rise in the number of patients undergoing treatment for vitiligo and the launch of Scenesse (afamelanotide) in 2014. The vitiligo therapeutics market will witness only one new drug approval in the forecast period. The new introduction in the market will be positioned as a novel therapy among moderately efficacious generics and is expected to be launched at a premium price, thus limiting its market penetration in initial years.
Scope of the Report
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Vitiligo Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Vitiligo Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Vitiligo Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Vitiligo Therapeutics market
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the market.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
For more information visit http://www.researchandmarkets.com/research/bda0ec/vitiligo_therapeut